Market news
Detailed price information for Intelligent Bio Solutions Inc (INBS-Q) from The Globe and Mail including charting and trades.
Recertification aligns with the FDA's newly amended Quality Management System Regulation and supports the Company's regulatory strategy as it pursues FDA clearance
All clinical data collection across the Company's FDA 510(k) clinical study program is complete; FDA submission on track for second half of 2026...
Study confirms the system can be effectively administered by operators with no specialist background...
The Company remains on track to submit its 510(k) package in calendar H2 2026, working toward planned entry into the multi-billion-dollar U.S. drug...
This is the newest page. Registered accounts read further back.